German biotech company InflaRx NV appointed Tony Gibney as a board member.
Gibney previously served as a managing director and co-head of the biotechnology investment team for Leerink Partners LLC.
InflaRx names board member
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
German biotech company InflaRx NV appointed Tony Gibney as a board member.
Gibney previously served as a managing director and co-head of the biotechnology investment team for Leerink Partners LLC.